RETACRIT Solution for injection Ref.[8605] Active ingredients: Epoetin zeta

Source: European Medicines Agency (EU)  Revision Year: 2020  Publisher: Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050, Bruxelles, Belgium

Product name and form

Retacrit 1 000 IU/0.3 ml solution for injection in pre-filled syringe.
Retacrit 2 000 IU/0.6 ml solution for injection in pre-filled syringe.
Retacrit 3 000 IU/0.9 ml solution for injection in pre-filled syringe.
Retacrit 4 000 IU/0.4 ml solution for injection in pre-filled syringe.
Retacrit 5 000 IU/0.5 ml solution for injection in pre-filled syringe.
Retacrit 6 000 IU/0.6 ml solution for injection in pre-filled syringe.
Retacrit 8 000 IU/0.8 ml solution for injection in pre-filled syringe.
Retacrit 10 000 IU/1 ml solution for injection in pre-filled syringe.
Retacrit 20 000 IU/0.5 ml solution for injection in pre-filled syringe.
Retacrit 30 000 IU/0.75 ml solution for injection in pre-filled syringe.
Retacrit 40 000 IU/1 ml solution for injection in pre-filled syringe.

Pharmaceutical Form

Solution for injection in pre-filled syringe (injection).

Clear, colourless solution.

Qualitative and quantitative composition

Retacrit 1 000 IU/0.3 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 0.3 ml solution for injection contains 1 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 3 333 IU epoetin zeta per ml.

Excipients with known effect: Each pre-filled syringe contains 0.15 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

Retacrit 2 000 IU/0.6 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 0.6 ml solution for injection contains 2 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 3 333 IU epoetin zeta per ml.

Excipients with known effect: Each pre-filled syringe contains 0.30 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

Retacrit 3 000 IU/0.9 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 0.9 ml solution for injection contains 3 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 3 333 IU epoetin zeta per ml.

Excipients with known effect: Each pre-filled syringe contains 0.45 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

Retacrit 4 000 IU/0.4 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 0.4 ml solution for injection contains 4 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 10 000 IU epoetin zeta per ml.

Excipients with known effect: Each pre-filled syringe contains 0.20 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

Retacrit 5 000 IU/0.5 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 0.5 ml solution for injection contains 5 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 10 000 IU epoetin zeta per ml.

Excipients with known effect: Each pre-filled syringe contains 0.25 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

Retacrit 6 000 IU/0.6 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 0.6 ml solution for injection contains 6 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 10 000 IU epoetin zeta per ml.

Excipients with known effect: Each pre-filled syringe contains 0.30 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

Retacrit 8 000 IU/0.8 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 0.8 ml solution for injection contains 8 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 10 000 IU epoetin zeta per ml.

Excipients with known effect: Each pre-filled syringe contains 0.40 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

Retacrit 10 000 IU/1 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 1.0 ml solution for injection contains 10 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 10 000 IU epoetin zeta per ml.

Excipients with known effect: Each pre-filled syringe contains 0.50 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

Retacrit 20 000 IU/0.5 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 0.5 ml solution for injection contains 20 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 40 000 IU epoetin zeta per ml.

Excipients with known effect: Each pre-filled syringe contains 0.25 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

Retacrit 30 000 IU/0.75 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 0.75 ml solution for injection contains 30 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 40 000 IU epoetin zeta per ml.

Excipients with known effect: Each pre-filled syringe contains 0.38 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

Retacrit 40 000 IU/1 ml solution for injection in pre-filled syringe: 1 pre-filled syringe with 1 ml solution for injection contains 40 000 international units (IU) epoetin zeta* (recombinant human erythropoietin). The solution contains 40 000 IU epoetin zeta per ml.

Excipient with known effect: Each pre-filled syringe contains 0.50 mg phenylalanine.

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’.

* Produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell line.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Epoetin zeta

Epoetin zeta is a recombinant human erythropoietin. Erythropoietin (EPO) is a glycoprotein hormone produced primarily by the kidney in response to hypoxia and is the key regulator of red blood cell (RBC) production. The 2 are indistinguishable on the basis of functional assays.

List of Excipients

Disodium phosphate dihydrate
Sodium dihydrogen phosphate dihydrate
Sodium chloride
Calcium chloride dihydrate
Polysorbate 20
Glycine
Leucine
Isoleucine
Threonine
Glutamic acid
Phenylalanine
Water for injections
Sodium hydroxide (pH adjuster)
Hydrochloric acid (pH adjuster)

Pack sizes and marketing

Retacrit 1 000 IU/0.3 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 0.3 ml solution.

Each pack contains 1 or 6 pre-filled syringes.

Retacrit 2 000 IU/0.6 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 0.6 ml solution.

Each pack contains 1 or 6 pre-filled syringes.

Retacrit 3 000 IU/0.9 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 0.9 ml solution.

Each pack contains 1 or 6 pre-filled syringes.

Retacrit 4 000 IU/0.4 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 0.4 ml solution.

Each pack contains 1 or 6 pre-filled syringes.

Retacrit 5 000 IU/0.5 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 0.5 ml solution.

Each pack contains 1 or 6 pre-filled syringes.

Retacrit 6 000 IU/0.6 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 0.6 ml solution.

Each pack contains 1 or 6 pre-filled syringes.

Retacrit 8 000 IU/0.8 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 0.8 ml solution.

Each pack contains 1 or 6 pre-filled syringes.

Retacrit 10 000 IU/1 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 1 ml solution.

Each pack contains 1 or 6 pre-filled syringes.

Retacrit 20 000 IU/0.5 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 0.5 ml solution.

Each pack contains 1, 4 or 6 pre-filled syringes.

Multipacks contain 6 (6 × 1) pre-filled syringes.

Retacrit 30 000 IU/0.75 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 0.75 ml solution.

Each pack contains 1, 4 or 6 pre-filled syringes.

Multipacks contain 4 (4 × 1) pre-filled syringes.

Retacrit 40 000 IU/1 ml solution for injection in pre-filled syringe:

Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.

Each pre-filled syringe contains 1 ml solution.

Each pack contains 1, 4 or 6 pre-filled syringes.

Multipacks contain 4 (4 × 1) pre-filled syringes.

Not all pack sizes may be marketed.

Marketing authorization holder

Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050, Bruxelles, Belgium

Marketing authorization dates and numbers

Retacrit 1 000 IU/0.3 ml solution for injection in pre-filled syringe:

EU/1/07/431/001 1 pre-filled syringe
EU/1/07/431/002 6 pre-filled syringes
EU/1/07/431/026 1 pre-filled syringe with needle guard
EU/1/07/431/027 6 pre-filled syringes with needle guard
EU/1/07/431/054 1 pre-filled syringe with needle-trap
EU/1/07/431/055 6 pre-filled syringes with needle-trap

Retacrit 2 000 IU/0.6 ml solution for injection in pre-filled syringe:

EU/1/07/431/003 1 pre-filled syringe
EU/1/07/431/004 6 pre-filled syringes
EU/1/07/431/028 1 pre-filled syringe with needle guard
EU/1/07/431/029 6 pre-filled syringes with needle guard
EU/1/07/431/056 1 pre-filled syringe with needle-trap
EU/1/07/431/057 6 pre-filled syringes with needle-trap

Retacrit 3 000 IU/0.9 ml solution for injection in pre-filled syringe:

EU/1/07/431/005 1 pre-filled syringe
EU/1/07/431/006 6 pre-filled syringes
EU/1/07/431/030 1 pre-filled syringe with needle guard
EU/1/07/431/031 6 pre-filled syringes with needle guard
EU/1/07/431/058 1 pre-filled syringe with needle-trap
EU/1/07/431/059 6 pre-filled syringes with needle-trap

Retacrit 4 000 IU/0.4 ml solution for injection in pre-filled syringe:

EU/1/07/431/007 1 pre-filled syringe
EU/1/07/431/008 6 pre-filled syringes
EU/1/07/431/032 1 pre-filled syringe with needle guard
EU/1/07/431/033 6 pre-filled syringes with needle guard
EU/1/07/431/060 1 pre-filled syringe with needle-trap
EU/1/07/431/061 6 pre-filled syringes with needle-trap

Retacrit 5 000 IU/0.5 ml solution for injection in pre-filled syringe:

EU/1/07/431/009 1 pre-filled syringe
EU/1/07/431/010 6 pre-filled syringes
EU/1/07/431/034 1 pre-filled syringe with needle guard
EU/1/07/431/035 6 pre-filled syringes with needle guard
EU/1/07/431/062 1 pre-filled syringe with needle-trap
EU/1/07/431/063 6 pre-filled syringes with needle-trap

Retacrit 6 000 IU/0.6 ml solution for injection in pre-filled syringe:

EU/1/07/431/011 1 pre-filled syringe
EU/1/07/431/012 6 pre-filled syringes
EU/1/07/431/036 1 pre-filled syringe with needle guard
EU/1/07/431/037 6 pre-filled syringes with needle guard
EU/1/07/431/064 1 pre-filled syringe with needle-trap
EU/1/07/431/065 6 pre-filled syringes with needle-trap

Retacrit 8 000 IU/0.8 ml solution for injection in pre-filled syringe:

EU/1/07/431/013 1 pre-filled syringe
EU/1/07/431/014 6 pre-filled syringes
EU/1/07/431/038 1 pre-filled syringe with needle guard
EU/1/07/431/039 6 pre-filled syringes with needle guard
EU/1/07/431/066 1 pre-filled syringe with needle-trap
EU/1/07/431/067 6 pre-filled syringes with needle-trap

Retacrit 10 000 IU/1 ml solution for injection in pre-filled syringe:

EU/1/07/431/015 1 pre-filled syringe
EU/1/07/431/016 6 pre-filled syringes
EU/1/07/431/040 1 pre-filled syringe with needle guard
EU/1/07/431/041 6 pre-filled syringes with needle guard
EU/1/07/431/068 1 pre-filled syringe with needle-trap
EU/1/07/431/069 6 pre-filled syringes with needle-trap

Retacrit 20 000 IU/0.5 ml solution for injection in pre-filled syringe:

EU/1/07/431/017 1 pre-filled syringe
EU/1/07/431/020 4 pre-filled syringes
EU/1/07/431/021 6 pre-filled syringes
EU/1/07/431/042 1 pre-filled syringe with needle guard
EU/1/07/431/045 4 pre-filled syringes with needle guard
EU/1/07/431/046 6 pre-filled syringes with needle guard
EU/1/07/431/051 6 (6 × 1) pre-filled syringes (multipack)
EU/1/07/431/070 1 pre-filled syringe with needle-trap
EU/1/07/431/071 4 pre-filled syringes with needle-trap
EU/1/07/431/072 6 pre-filled syringes with needle-trap

Retacrit 30 000 IU/0.75 ml solution for injection in pre-filled syringe:

EU/1/07/431/018 1 pre-filled syringe
EU/1/07/431/022 4 pre-filled syringes
EU/1/07/431/023 6 pre-filled syringes
EU/1/07/431/043 1 pre-filled syringe with needle guard
EU/1/07/431/047 4 pre-filled syringes with needle guard
EU/1/07/431/048 6 pre-filled syringes with needle guard
EU/1/07/431/052 4 (4 × 1) pre-filled syringes (multipack)
EU/1/07/431/073 1 pre-filled syringe with needle-trap
EU/1/07/431/074 4 pre-filled syringes with needle-trap
EU/1/07/431/075 6 pre-filled syringes with needle-trap

Retacrit 40 000 IU/1 ml solution for injection in pre-filled syringe:

EU/1/07/431/019 1 pre-filled syringe
EU/1/07/431/024 4 pre-filled syringes
EU/1/07/431/025 6 pre-filled syringes
EU/1/07/431/044 1 pre-filled syringe with needle guard
EU/1/07/431/049 4 pre-filled syringes with needle guard
EU/1/07/431/050 6 pre-filled syringes with needle guard
EU/1/07/431/053 4 (4 × 1) pre-filled syringes (multipack)
EU/1/07/431/076 1 pre-filled syringe with needle-trap
EU/1/07/431/077 4 pre-filled syringes with needle-trap
EU/1/07/431/078 6 pre-filled syringes with needle-trap

Date of first authorisation: 18 December 2007
Date of latest renewal: 15 November 2012

Drugs

Drug Countries
RETACRIT Austria, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.